Increased frequency of positive family history of dementia in sporadic CJD

Neurobiology of Aging

Volumn 30, Issue 4, 2009, Pages 615-621

  Krasnianski, Anna ^a   von Ahsen, Nicolas ^b   Heinemann, Uta ^a   Meissner, Bettina ^a   Schulz Schaeffer, Walter J ^b   Kretzschmar, Hans A ^c   Armstrong, Victor W ^b   Zerr, Inga ^a  

^a TSE   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer's disease; ApoE; Family history of dementia; M129V polymorphism; sCJD

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 61649125854     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.07.014     Document Type: Article

References (30)

1. Alpérovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C., and Will R.G. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353 (1999) 1673-1674
2. Amouyel P., Vidal O., Launay J.M., and Laplanche J.L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human spongiform encephalopathies. Lancet 344 (1994) 1315-1318
3. Baum L., Lam L.C., Kowok T., Lee J., Chiu H.F., Mok V.C., Wong A., Chen X., Cheung W.S., Pang C.P., Ma S.L., Tang N.L., Wong K.S., and Ng H.K. Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement. Geriatr. Cog. Disord. 22 (2006) 301-305
4. Berr C., Richard F., Dufouil C., Amant C., Alperovitch A., and Amouyel P. Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. Neurology 51 (1998) 734-737
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
6. Davidson Y., Gibbons L., Purandare N., Byrne J., Hardicre J., Wren J., Payton A., Pendleton N., Horan M., Burns A., and Mann D.M. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dement. Geriat. Cog. Disord. 22 (2006) 15-19
7. Del Bo R., Scarlato M., Ghezzi S., Martinelli-Boneschi F., Fenoglio C., Galimberti G., Galbiati S., Virgilio R., Galimberti D., Scarpini E., Bresolin N., and Comi G.P. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol. Aging 27 (2006) (Epub.)
8. Dermaut B., Croes E.A., Rademakers R., Van den Broeck M., Cruts M., Hofman A., van Duijn C.M., and Van Broeckhoven C. PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease. Ann. Neurol. 53 (2003) 409-412
9. Huang Y. Apolipoprotein E and Alzheimer's disease. Neurology 66 (2006) S79-S85
10. Kitamoto T., Shin R.W., Doh-Ura K., Tomokane N., Miyazono M., Muramoto T., and Tateishi J. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140 (1992) 1285-1294
11. Kovacs G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., Van Duijn C., Collins S., Boyd A., Guilivi A., Coulthart M., Delasnerie-Laupretre N., Brandel J.P., Zerr I., Kretzschmar H., de Pedro-Cuesta J., Calero-Lara M., Glatzel M., Aguzzi A., Bishop M., Knight R., Belay G., Will R., and Mitrova E. Genetic prion disease: the EUROCJD experience. Hum. Genet. 118 (2005) 166-174
12. Kretzschmar H.A., Ironside J.W., DeArmond S.J., and Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch. Neurol. 53 (1996) 913-920
13. Ladogana A., Puopolo M., Croes E.A., Budka H., Jarius C., Collins S., Klug G.M., Sutcliffe T., Giulivi A., Alperovitch A., Delasnerie-Laupretre N., Brandel J.-P., Poser S., Kretzschmar H., Rietveld I., Mitrova E., de Pedro-Cuesta J., Martinez-Martin P., Glatzel M., Aguzzi A., Knight R., Ward H., Pocchiari M., van Duijn C.M., Will R.G., and Zerr I. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64 (2005) 1586-1591
14. Miettinen O.S., and Nurminen N. Comparative analysis of two rates. Stat. Med. 4 (1985) 213-226
15. Mollenhauer B., Cepek L., Bibl M., Wiltfang J., Schulz-Schaeffer W.J., Ciesielczyk B., Neumann M., Steinacker P., Kretzschmar H.A., Poser S., Trenkwalder C., and Otto M. Tau protein, Abeta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement. Geriat. Cog. Disord. 19 (2005) 164-170
16. Nakagawa Y., Kitamoto T., Furukawa H., Ogomori K., and Tateishi J. Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt-Jakob disease patients. Neurosci. Lett. 187 (1995) 209-211 ISSN: 0304-3940
17. O'Brien J., Ames D., and Burns A. Dementia. 2nd ed. (2000), Arnold
18. Palmer M.S., Dryden A.J., Hughes J.T., and Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 (1991) 340-342 published erratum appears in Nature 352 (6335) (8 August 1991) 547 (see comments)
19. Raymond M., and Rousset F. Population genetics software for exact tests and ecumenicism. J. Heredity 86 (1995) 248-249
20. Riemenschneider M., Diehl J., Müller U., Forstl H., and Kurz A. Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J. Neurol. Neurosurg. Psychiatry 72 (2002) 639-641
21. Salvatore M., Seeber A.C., Nacmias B., Petraroli R., D'Alessandro M., Sorbi S., and Pocchiari M. Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci. Lett. 199 (1995) 95-98
22. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 (1993) 710-711 (see comments)
23. Schulz-Schaeffer W.J., Tschoke S., Kranefuss N., Drose W., Hause-Reitner D., Giese A., Groschup M.H., and Kretzschmar H.A. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am. J. Pathol. 156 (2000) 51-56
24. van Duijn C.M., Delasnerie-Lauprêtre N., Masullo C., Zerr I., de Silva R., Wientjens D.P.W.M., Brandel J.-P., Weber T., Bonavita V., Zeidler M., Alpérovitch A., Poser S., Granieri E., Hofman A., Will R.G., and European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob Disease (CJD). Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 351 (1998) 1081-1085
25. Van Everbroeck B., Green A., Pals P., Martin J.J., and Cras P. Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. J. Alzheimers Dis. 1 (1999) 419-424
26. WHO. Human transmissible spongiform encephalopathies. Wkly. Epidemiol. Rec. 47 (1998) 361-365
27. Windl O., Dempster M., Estibeiro J.P., Lathe R., de Silva R., Esmonde T., Will R., Springbett A., Campbell T.A., Sidle K.C., Palmer M.S., and Collinge J. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum. Genet. 98 (1996) 259-264
28. Zannis V.I., Just P.W., and Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am. J. Hum. Genet. 33 (1981) 11-24
29. Zerr I., Helmhold M., Poser S., Armstrong V.W., and Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch. Neurol. 53 (1996) 1233-1238
30. Zerr I., Pocchiari M., Collins S., Brandel J.P., de Pedro Cuesta J., Knight R.S.G., Bernheimer H., Cardone F., Delasnerie-Lauprêtre N., Cuadrado Corrales N., Ladogana A., Fletcher A., Bodemer M., Awan T., Ruiz Bremón A., Budka H., Laplanche J.L., Will R.G., and Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55 (2000) 811-815